Shanghai Junshi Biosciences (SHA:688180, HKG:1877) said Shanghai Tanying Investment Partnership is planning to reduce its shareholding in the company by up to over 20.5 million shares.
Shanghai Tanying Investment Partnership holds 38.9 million China-listed shares in the company, according to a Monday Hong Kong bourse filing.